Related content

Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide

By Hesketh Paul   Younger Jerry   Sanz-Altamira Pedro   Hayden Melissa   Bushey Julie   Trainor Brian   Krentzin Michael   Nowd Peter   Arnaoutakis Konstantinos   Hesketh Ann  

Supportive Care in Cancer, Vol. 17, Iss. 8, 2009-08 ,pp. : 1065-1070

Springer Publishing Company

Access to resources Recommend Favorite

The Antiemetic Efficacy of Oral Ondansetron plus Intravenous Dexamethasone in Patients with Gynecologic Malignancies Receiving Carboplatin-Based Chemotherapy

By Markman M.   Kennedy A.   Webster K.   Peterson G.   Kulp B.   Belinson J.  

Gynecologic Oncology, Vol. 78, Iss. 1, 2000-07 ,pp. : 43-46

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics and Tolerance of Vinorelbine in Elderly Patients with Metastatic Breast Cancer

By Sorio R.   Robieux I.   Galligioni E.   Freschi A.   Colussi A.M.   Crivellari D.   Saracchini S.   Monfardini S.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 301-303

Elsevier

Access to resources Recommend Favorite

Population pharmacokinetics of short intravenous vinorelbine infusions in patients with metastatic breast cancer

By Deporte-Fety R.   Simon N.   Fumoleau P.   Campone M.   Kerbrat P.   Bonneterre J.   Fargeot P.   Urien S.  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 3, 2004-03 ,pp. : 233-238

Springer Publishing Company

Access to resources Recommend Favorite

Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin

By Choi Chel   Kim Min   Park Jin-Young   Yoon Aera   Kim Ha-Jeong   Lee Yoo-Young   Kim Tae-Joong   Lee Jeong-Won   Kim Byoung-Gie   Bae Duk-Soo  

Supportive Care in Cancer, Vol. 22, Iss. 5, 2014-05 ,pp. : 1181-1187

Springer Publishing Company

Access to resources Recommend Favorite